Thalidomide-O-amido-C8-NH2 (TFA)
| Catalog Number | Pack Size | List Price* | Quantity | |
|---|---|---|---|---|
| HY-103614-25MG | 25 mg | 178,00 | Add | |
| HY-103614-50MG | 50 mg | 280,00 | Add | |
| HY-103614-100MG | 100 mg | 456,00 | Add | |
| HY-103614-S-1ST | Sample | Inquire |
* CHF, excl. 8.1% VAT and shipping costs
Product Description
Best price guarantee – we offer you the lowest price in Switzerland. Please contact us for a quote if needed.
Thalidomide-O-amido-C8-NH2 TFA (Cereblon Ligand -Linker Conjugates 2 TFA) is a synthesized E3 ligase ligand-linker conjugate that incorporates the Thalidomide based cereblon ligand and a linker used in PROTAC technology.
| Category | Peptide |
| Supplier | MedChem Express |
| Regulatory Status | RUO |
| Research Field | s, PROTAC |
| Format | Solubility: DMSO : ≥ 131 mg/mL |
| Grade | Clinical information: No Development Reported |
| Purity | 99.11% |
| Molecular Formula | C25H31F3N4O8 |
| Molecular Weight | 572.53 |
| CAS-Number | 1950635-16-1 |
| Storage Conditions | 4°C (Powder, sealed storage, away from moisture) |
| Tech. Data Sheet | View datasheet |
| Link To Supplier | http://www.medchemexpress.com |
| Shipping Details | Room Temperature |
| Material Safety Data Sheet | Download PDF |
